GlassScriptPhysician profile
Frances D Salter
NPI 1225082902
$2,525.48
in general payments reported to CMS, 2019-2025
20 companies · $212 in 2025
The $212 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $583 · 2020: $365 · 2021: $586 · 2022: $228 · 2023: $376 · 2024: $175 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $762.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $420.55 | 2019-2023 | Austedo |
| Lilly USA, LLC | $278.42 | 2019-2022 | |
| Amgen INC. | $246.51 | 2019-2022 | |
| Galt Pharmaceuticals, LLC | $199.50 | 2023 | Orphengesic Forte |
| Novo Nordisk INC | $196.08 | 2019-2024 | Ozempic, Rybelsus |
| Paratek Pharmaceuticals, INC. | $185.78 | 2021-2025 | Nuzyra, Xhance |
| Janssen Pharmaceuticals, INC | $174.36 | 2019-2022 | |
| Horizon Therapeutics Plc | $152.63 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $122.92 | 2022-2023 | Farxiga |
| Phathom Pharmaceuticals, INC. | $114.90 | 2025 | Voquezna |
| Esperion Therapeutics, INC. | $112.90 | 2021-2022 | |
| Harmony Biosciences LLC | $70.52 | 2024 | |
| Upsher-Smith Laboratories LLC | $57.54 | 2021 | |
| Novartis Pharmaceuticals Corporation | $53.63 | 2019-2022 | |
| Pfizer INC. | $41.65 | 2019-2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $26.77 | 2021 | |
| Abbvie INC. | $21.75 | 2023 | Dalvance |
| Biohaven Pharmaceutical Holding Company LTD. | $19.97 | 2022 | |
| Exact Sciences Corporation | $14.66 | 2023 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frances Salter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.